{"id":942296,"date":"2026-03-05T11:59:00","date_gmt":"2026-03-05T16:59:00","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-selected-for-best-innovation-competition-at-crt-2026\/"},"modified":"2026-03-05T11:59:00","modified_gmt":"2026-03-05T16:59:00","slug":"autonomix-medical-selected-for-best-innovation-competition-at-crt-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-selected-for-best-innovation-competition-at-crt-2026\/","title":{"rendered":"Autonomix Medical Selected for Best Innovation Competition at CRT 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">\n        <b>THE WOODLANDS, TX, March  05, 2026  (GLOBE NEWSWIRE) &#8212; <\/b><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3r1z4n0QdsAZw4UM3O3hixQfULwxuXwlHpMz6Yhs3dRG7eNhdecCCH6XXOdIaCdlwpUhS3RfNtGpbFyzRNdyys2DMl1Xn-fWE_7GQXFtfcccZ8pZ2wc7kvIzgXn7F7gwmIKsg47gZBO3SRseC7wZD_ivPAUUjpL3aT1F5seEpNYFSsuYG2zggIwJ6ysMk8fcyo5b7qe5_fTl69PQdOaHDEX4Qi9iFeSxFDQaOBjbhkta1zb5g5t4j1I2ruObTcxInwyPq2EjHPG-azt377tKLQ==\" rel=\"nofollow\" target=\"_blank\">Autonomix Medical, Inc.<\/a>\u00a0(NASDAQ: AMIX) (\u201cAutonomix\u201d or the \u201cCompany\u201d), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced that its presentation titled, \u201c<i>Illuminating The Nervous System With Transvascular Precision-guided Technology,<\/i>\u201d has been selected for oral presentation in the Best Innovation Competition at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LKqiYqjgrrSHD1Y3mSxRnfhyvCsKot7BUG5ObTuqTJwDU9UKLNB3NrrbdYBpl6r_5aqdYEzwfP1X0phQsqofnieHclsuNfvsGTit55LkbEcI1132cffkhwwoj24XokP8CBuKH4cnB03a5QWznBBZKA==\" rel=\"nofollow\" target=\"_blank\">Cardiovascular Research Technologies (CRT) 2026<\/a>.<\/p>\n<p align=\"justify\">The presentation will be delivered by <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=TH9g-Y897_o7fZVyKqLFA4Qbcrbd85O6In8w1iccPwA1SPjwlSv7uNFzFC6JnkG1UE08gCBGbgPKglK4eaZehF2Jz3H_dAmd-wAs20paNoZWqHdkJQqStylJCvrZy5SHgxOTtH4GG131lqPyZqo_XA==\" rel=\"nofollow\" target=\"_blank\">Chief Executive Officer, Brad Hauser<\/a>, on Monday, March 9, 2026, from 4:19 PM to 4:27 PM ET in the International Ballroom \u2013 West.<\/p>\n<p align=\"justify\">The CRT Best Innovation Competition highlights transformative technologies with the potential to meaningfully impact patient care. Selection for oral presentation reflects the program\u2019s emphasis on scientific innovation, technical differentiation and clinical relevance.<\/p>\n<p align=\"justify\">\u201cBeing selected for CRT\u2019s Best Innovation Competition is a strong validation of our precision-guided, transvascular approach to interrogating and treating the nervous system,\u201d commented Brad Hauser, CEO of Autonomix. \u201cOur technology is designed to provide physicians with unprecedented insight into peripheral nerve signaling.\u201d<\/p>\n<p align=\"justify\">CRT is one of the world\u2019s leading educational forums for interventional cardiovascular medicine, with Top Abstract podium selections representing the highest-scoring submissions based on scientific merit, innovation and clinical relevance. For more information, please visit the conference website <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Pp7oEo6kx02fhR6KKZtKIrGhqv38PAOrycbFmbIpvcbYUn7glIxh01EkqMCZ6K_q910CfMnBlXa1yh4JH-QD9g==\" rel=\"nofollow\" target=\"_blank\">here<\/a>.<\/p>\n<p align=\"justify\">\n        <b>About Autonomix Medical, Inc.<\/b>\n      <\/p>\n<p align=\"justify\">Autonomix is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company\u2019s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body.<\/p>\n<p align=\"justify\">We are initially developing this technology for the treatment of pain, with initial trials focused on pancreatic cancer, a condition that causes debilitating pain and is without a reliable solution. Our technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Our technology is investigational and has not yet been cleared for marketing in the United States.<\/p>\n<p>For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=l10xr3Mp6zwUvC_wihhIZKPHYWq3wUPMFzbplW6vHmYvXGxC5uqYEHM96-01YMaLov1x_M6pxeopvS8DnEa61Q==\" rel=\"nofollow\" target=\"_blank\">autonomix.com<\/a> and connect with the Company on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fu3Zx_8UZuiMZy-NlZok0EHYfUebjfJIx3cew0T-JUrPfSIaFFWA1m8BzmrJaqCk5UwzTNviCJ_n0G2duzHMJA==\" rel=\"nofollow\" target=\"_blank\">X<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QIqoMRsmAAtRjyWknO6rtUMFuJfqv8f90rXwrgDSSirMjmNx9OQFjvCFiYLG9_Q9xRq71wStkLVnsX4sIcC06w8ntBnsvzOk5y2-ntTGlhEfE0vHatJgjzTVKf7U_AQH\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=szUibYrKrUNFsnnU7ZTFH3cWnoySd9ojPokZ2lg2a3HQEvv1hx8DJfIFZtAcb2yj0s0xHd5COs1RADwsUI1L1mxwFvcynCiJW2Iq3X0pkKg=\" rel=\"nofollow\" target=\"_blank\">Instagram<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fOcOUuDg-5yf5O1JC0vLs2ojf42us83t8MRTCVowt4ZixVZnMG2eMZ0M5oJC62gwQrofYKrV60cgZbxpYLH-lDYrD57l1cHsZqzT0PMQzirkaY57-EjY-oiYKMQfacXL\" rel=\"nofollow\" target=\"_blank\">Facebook<\/a>. <\/p>\n<p><b>Forward Looking Statements<\/b><\/p>\n<p align=\"justify\">Some of the statements in this release are \u201cforward-looking statements,\u201d which involve risks and uncertainties. Such forward-looking statements can be identified by the use of words such as \u201cshould,\u201d \u201cmight,\u201d \u201cmay,\u201d \u201cintends,\u201d \u201canticipates,\u201d \u201cbelieves,\u201d \u201cestimates,\u201d \u201cprojects,\u201d \u201cforecasts,\u201d \u201cexpects,\u201d \u201cplans,\u201d and \u201cproposes.\u201d Forward-looking statements in this press release include expectations regarding the potential effectiveness and clinical benefits of Autonomix&#8217;s nerve-targeted treatments for pancreatic cancer pain and other conditions.<\/p>\n<p align=\"justify\">Although Autonomix believes that the expectations reflected in these forward-looking statements are based on reasonable assumptions, there are a number of risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading \u201cRisk Factors\u201d and elsewhere in the Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (SEC) on May 29, 2025, and from time to time, our other filings with the SEC. Forward-looking statements speak only as of the date of this press release and Autonomix does not undertake any duty to update any forward-looking statements except as may be required by law.<\/p>\n<p align=\"justify\">\n        <b>Investor and Media Contact<\/b>\n      <\/p>\n<p align=\"justify\">JTC Team, LLC<br \/>Jenene Thomas<br \/>908.824.0775<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=l10xr3Mp6zwUvC_wihhIZMVkpz12M1gdP8W0R9fNyrUxLZdVw3Yw8JWrGyvfpQ31oihImnRS3WOatczAOyHCSAjQnHvDoZyNI3TITBpVX6I=\" rel=\"nofollow\" target=\"_blank\">autonomix@jtcir.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NTQyMSM3NDY2NDI2IzUwMDExOTk5Mg==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MWJmNWI2ZTQtZDU4OS00OGIzLTlhNDItMzlhOGYwMjhiNzQyLTUwMDExOTk5Mi0yMDI2LTAzLTA1LWVu\/tiny\/Autonomix-Medical-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>THE WOODLANDS, TX, March 05, 2026 (GLOBE NEWSWIRE) &#8212; Autonomix Medical, Inc.\u00a0(NASDAQ: AMIX) (\u201cAutonomix\u201d or the \u201cCompany\u201d), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced that its presentation titled, \u201cIlluminating The Nervous System With Transvascular Precision-guided Technology,\u201d has been selected for oral presentation in the Best Innovation Competition at Cardiovascular Research Technologies (CRT) 2026. The presentation will be delivered by Chief Executive Officer, Brad Hauser, on Monday, March 9, 2026, from 4:19 PM to 4:27 PM ET in the International Ballroom \u2013 West. The CRT Best Innovation Competition highlights transformative technologies with the potential to meaningfully impact patient care. Selection for oral presentation reflects the program\u2019s emphasis on scientific innovation, technical differentiation and clinical relevance. \u201cBeing &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-selected-for-best-innovation-competition-at-crt-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Autonomix Medical Selected for Best Innovation Competition at CRT 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-942296","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Autonomix Medical Selected for Best Innovation Competition at CRT 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-selected-for-best-innovation-competition-at-crt-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Autonomix Medical Selected for Best Innovation Competition at CRT 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"THE WOODLANDS, TX, March 05, 2026 (GLOBE NEWSWIRE) &#8212; Autonomix Medical, Inc.\u00a0(NASDAQ: AMIX) (\u201cAutonomix\u201d or the \u201cCompany\u201d), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced that its presentation titled, \u201cIlluminating The Nervous System With Transvascular Precision-guided Technology,\u201d has been selected for oral presentation in the Best Innovation Competition at Cardiovascular Research Technologies (CRT) 2026. The presentation will be delivered by Chief Executive Officer, Brad Hauser, on Monday, March 9, 2026, from 4:19 PM to 4:27 PM ET in the International Ballroom \u2013 West. The CRT Best Innovation Competition highlights transformative technologies with the potential to meaningfully impact patient care. Selection for oral presentation reflects the program\u2019s emphasis on scientific innovation, technical differentiation and clinical relevance. \u201cBeing &hellip; Continue reading &quot;Autonomix Medical Selected for Best Innovation Competition at CRT 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-selected-for-best-innovation-competition-at-crt-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-05T16:59:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NTQyMSM3NDY2NDI2IzUwMDExOTk5Mg==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-selected-for-best-innovation-competition-at-crt-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-selected-for-best-innovation-competition-at-crt-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Autonomix Medical Selected for Best Innovation Competition at CRT 2026\",\"datePublished\":\"2026-03-05T16:59:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-selected-for-best-innovation-competition-at-crt-2026\\\/\"},\"wordCount\":579,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-selected-for-best-innovation-competition-at-crt-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2NTQyMSM3NDY2NDI2IzUwMDExOTk5Mg==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-selected-for-best-innovation-competition-at-crt-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-selected-for-best-innovation-competition-at-crt-2026\\\/\",\"name\":\"Autonomix Medical Selected for Best Innovation Competition at CRT 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-selected-for-best-innovation-competition-at-crt-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-selected-for-best-innovation-competition-at-crt-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2NTQyMSM3NDY2NDI2IzUwMDExOTk5Mg==\",\"datePublished\":\"2026-03-05T16:59:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-selected-for-best-innovation-competition-at-crt-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-selected-for-best-innovation-competition-at-crt-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-selected-for-best-innovation-competition-at-crt-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2NTQyMSM3NDY2NDI2IzUwMDExOTk5Mg==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2NTQyMSM3NDY2NDI2IzUwMDExOTk5Mg==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-selected-for-best-innovation-competition-at-crt-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Autonomix Medical Selected for Best Innovation Competition at CRT 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Autonomix Medical Selected for Best Innovation Competition at CRT 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-selected-for-best-innovation-competition-at-crt-2026\/","og_locale":"en_US","og_type":"article","og_title":"Autonomix Medical Selected for Best Innovation Competition at CRT 2026 - Market Newsdesk","og_description":"THE WOODLANDS, TX, March 05, 2026 (GLOBE NEWSWIRE) &#8212; Autonomix Medical, Inc.\u00a0(NASDAQ: AMIX) (\u201cAutonomix\u201d or the \u201cCompany\u201d), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced that its presentation titled, \u201cIlluminating The Nervous System With Transvascular Precision-guided Technology,\u201d has been selected for oral presentation in the Best Innovation Competition at Cardiovascular Research Technologies (CRT) 2026. The presentation will be delivered by Chief Executive Officer, Brad Hauser, on Monday, March 9, 2026, from 4:19 PM to 4:27 PM ET in the International Ballroom \u2013 West. The CRT Best Innovation Competition highlights transformative technologies with the potential to meaningfully impact patient care. Selection for oral presentation reflects the program\u2019s emphasis on scientific innovation, technical differentiation and clinical relevance. \u201cBeing &hellip; Continue reading \"Autonomix Medical Selected for Best Innovation Competition at CRT 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-selected-for-best-innovation-competition-at-crt-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-03-05T16:59:00+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NTQyMSM3NDY2NDI2IzUwMDExOTk5Mg==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-selected-for-best-innovation-competition-at-crt-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-selected-for-best-innovation-competition-at-crt-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Autonomix Medical Selected for Best Innovation Competition at CRT 2026","datePublished":"2026-03-05T16:59:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-selected-for-best-innovation-competition-at-crt-2026\/"},"wordCount":579,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-selected-for-best-innovation-competition-at-crt-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NTQyMSM3NDY2NDI2IzUwMDExOTk5Mg==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-selected-for-best-innovation-competition-at-crt-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-selected-for-best-innovation-competition-at-crt-2026\/","name":"Autonomix Medical Selected for Best Innovation Competition at CRT 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-selected-for-best-innovation-competition-at-crt-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-selected-for-best-innovation-competition-at-crt-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NTQyMSM3NDY2NDI2IzUwMDExOTk5Mg==","datePublished":"2026-03-05T16:59:00+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-selected-for-best-innovation-competition-at-crt-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-selected-for-best-innovation-competition-at-crt-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-selected-for-best-innovation-competition-at-crt-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NTQyMSM3NDY2NDI2IzUwMDExOTk5Mg==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NTQyMSM3NDY2NDI2IzUwMDExOTk5Mg=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-selected-for-best-innovation-competition-at-crt-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Autonomix Medical Selected for Best Innovation Competition at CRT 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/942296","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=942296"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/942296\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=942296"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=942296"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=942296"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}